Science
SS-31 and the Membrane That Powers Your Cells
Why the organization of a mitochondrial membrane matters for energy production—and where elamipretide enters the picture.
Every heartbeat, muscle contraction, and newly assembled protein depends on a supply of usable energy. Much of that supply comes from mitochondria, structures inside cells that convert energy from food into a form cellular machinery can use.
SS-31, also called elamipretide, is a four-residue peptide studied for its interactions with the inner mitochondrial membrane. Its story begins with a surprising idea: the arrangement and chemistry of a membrane help determine how efficiently a cell can make energy.
ATP turns available energy into cellular work
Food contains chemical energy, but cells need a convenient way to transfer it to their working parts. ATP, adenosine triphosphate, serves that role. Reactions that convert ATP to ADP can be coupled to processes such as muscle contraction and transport across membranes.
Cells continuously rebuild ATP from ADP. Mitochondria perform much of this work through a process called oxidative phosphorylation.
A mitochondrion has an outer membrane and a highly folded inner membrane. The folds, called cristae, provide space and organization for the protein machinery that links nutrient-derived energy to ATP production.
A microscopic gradient drives the machinery
Molecules generated during nutrient metabolism deliver electrons to the electron transport chain, a series of proteins in the inner membrane. As electrons move along the chain, some of these proteins pump protons—positively charged hydrogen ions—across the membrane.
This produces an electrochemical gradient: a difference in proton concentration and electrical charge between the two sides. Like water held behind a dam, that difference stores energy.
Like water held behind a dam, that difference stores energy.
Protons flow back through ATP synthase, an enzyme that uses the flow to help manufacture ATP. Oxygen accepts electrons at the end of the transport chain and contributes to the formation of water.
The connection between electron transfer, proton movement, and ATP production is called coupling. It depends on a functioning membrane and properly organized proteins.
Cardiolipin helps organize the energy system
Cardiolipin is a specialized phospholipid concentrated in the inner mitochondrial membrane. It helps support the membrane’s architecture and the operation of its associated proteins.
One of those partners is cytochrome c, a small protein that carries electrons between components of the electron transport chain. Under certain conditions, its interaction with cardiolipin can also promote peroxide-related reactions that damage the lipid.
In experiments reported by Birk and colleagues, SS-31 interacted with cardiolipin and influenced its relationship with cytochrome c. In the tested systems, it inhibited the complex’s peroxidase activity, supported electron-carrier function, and improved measures of mitochondrial respiration and ATP synthesis.[1]
This is why SS-31 is best understood through mitochondrial membrane biology. Its proposed effects involve the relationship among lipids, proteins, and energy-producing reactions.
What energy measurements can tell us
A 2021 randomized trial studied 39 adults aged 60–85 selected for reduced muscle mitochondrial function. After a two-hour intravenous infusion, the percentage change in maximum ATP-production capacity favored elamipretide. The absolute-change comparison narrowly missed the conventional statistical threshold. The study found no significant improvement in the tested muscle’s fatigue resistance, and the ATP-capacity difference was absent at day seven.[2]
The larger MMPOWER-3 trial studied 218 people with primary mitochondrial myopathy, a group of genetic muscle disorders affecting mitochondrial function. Over 24 weeks, daily subcutaneous elamipretide did not improve the trial’s primary walking-distance and fatigue outcomes compared with placebo.[3]
These studies distinguish energy-production capacity from physical performance. ATP supply contributes to muscle function, but strength, endurance, and fatigue also depend on circulation, nerves, muscle structure, and the underlying condition.
SS-31 makes mitochondrial medicine tangible: a small peptide can interact with a membrane lipid associated with energy production. Understanding its potential requires following that relationship from molecular chemistry through tissue function to the outcome a person experiences.
References
- Birk and colleagues. Targeting cardiolipin and the cytochrome c complex. British Journal of Pharmacology, 2014. PubMed ↗
- Roshanravan and colleagues. ATP production after elamipretide in older adults. PLOS ONE, 2021. PubMed ↗
- Karaa and colleagues. The MMPOWER-3 randomized clinical trial. Neurology, 2023. PubMed ↗
RSVP for the next webinar Talk to a practice consultantWe reply within one business day.
Get a free state- and peptide-specific compliance memo + informed consent template →
More articles
- GHK-Cu and the Cellular Craft of Tissue Repair
- How Semaglutide and Tirzepatide Change the Conversation Between Cells
- Glutathione and the Chemistry of Cellular Defense
- The regulatory misconception: FDA approval vs. standard of care
- Potential legal exposure associated with purchasing ineligible compounded peptides from a 503A pharmacy
- Compounded tirzepatide vs. Mounjaro: why patients are asking, and how it fits a practice
- How to add peptide therapy to your practice: a step-by-step overview
- A practical telehealth workflow for peptide prescribing
- Building a peptide patient program that patients stick with